Medipharm Labs Corp (LABS) — Financial Flexibility Index
Medipharm Labs Corp (LABS) has a Financial Flexibility Index of -0.02x as of September 2025. Free cash flow of CA$-142.00K (operating CF CA$-158.00K minus capex CA$16.00K) represents 0% of total liabilities (CA$8.74 Million). Also explore net asset growth rate of Medipharm Labs Corp to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Medipharm Labs Corp Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Medipharm Labs Corp across 9 annual periods. Check how strategically is Medipharm Labs Corp's equity deployed to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Medipharm Labs Corp (2016–2024)
Year-by-year free cash flow to debt coverage for Medipharm Labs Corp. For the full company profile including market capitalisation, see LABS stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CAD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.45x | CA$-4.71 Million | CA$-4.86 Million | CA$10.55 Million | ▲ +58.9% |
| 2023 | -1.09x | CA$-11.87 Million | CA$-12.34 Million | CA$10.93 Million | ▲ +32.2% |
| 2022 | -1.60x | CA$-15.21 Million | CA$-16.07 Million | CA$9.49 Million | ▼ -18.8% |
| 2021 | -1.35x | CA$-12.43 Million | CA$-13.21 Million | CA$9.21 Million | ▼ -77.4% |
| 2020 | -0.76x | CA$-30.27 Million | CA$-37.77 Million | CA$39.82 Million | ▼ -498.5% |
| 2019 | 0.19x | CA$7.17 Million | CA$-25.27 Million | CA$37.60 Million | ▼ -17.9% |
| 2018 | 0.23x | CA$3.46 Million | CA$-11.11 Million | CA$14.89 Million | ▼ -74.6% |
| 2017 | 0.92x | CA$2.31 Million | CA$166.00K | CA$2.52 Million | ▼ -98.0% |
| 2016 | 44.71x | CA$2.09 Million | CA$-54.69K | CA$46.73K | — |